Fig. 1
From: KLF7: a new candidate biomarker and therapeutic target for high-grade serous ovarian cancer
KLF7 is a powerful prognostic biomarker for Overall Survival (OS) in late-stage HGSOC patients. a The prognostic value of KLF7 was explored in six publicly available ovarian cancer transcriptome datasets. b, c Kaplan-Meier survival curves for the probability of OS in GSE26712 patients cohort (b, n = 185) and TCGA-OV patients cohort (c, n = 266). KLF7 expression values were converted into discrete variables by dividing the available population cohorts into “high KLF7” and “low KLF7” based on the cutoff suggested by CutOff Finder: b KLF7 Cutoff = 6.861; c KLF7 Cutoff = 175. P-value in the plot represents the result of log-rank test